Cardillo, Carmine
 Distribuzione geografica
Continente #
NA - Nord America 1.638
EU - Europa 1.627
AS - Asia 508
OC - Oceania 6
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
Totale 3.790
Nazione #
US - Stati Uniti d'America 1.629
DE - Germania 338
PL - Polonia 308
SE - Svezia 234
CN - Cina 213
IT - Italia 195
UA - Ucraina 182
SG - Singapore 132
IE - Irlanda 98
RU - Federazione Russa 72
FR - Francia 65
ID - Indonesia 57
FI - Finlandia 53
IN - India 51
GB - Regno Unito 40
TR - Turchia 24
BE - Belgio 21
IR - Iran 10
AU - Australia 5
CA - Canada 5
CH - Svizzera 4
JP - Giappone 4
KR - Corea 4
NL - Olanda 4
VN - Vietnam 4
CZ - Repubblica Ceca 3
ES - Italia 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
CL - Cile 2
CO - Colombia 2
DK - Danimarca 2
GT - Guatemala 2
IQ - Iraq 2
MX - Messico 2
MY - Malesia 2
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
EU - Europa 1
HR - Croazia 1
JO - Giordania 1
LY - Libia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 3.790
Città #
Warsaw 306
Chandler 291
Ashburn 150
Singapore 110
Dublin 91
Fairfield 79
San Mateo 79
Jacksonville 77
Ann Arbor 74
Wilmington 71
Houston 67
Woodbridge 65
Jakarta 56
New York 54
Seattle 46
Nanjing 44
Cattolica 41
Boston 36
Milan 36
Beijing 35
Lawrence 33
Marseille 30
Moscow 30
Saint Petersburg 30
Dearborn 28
Nanchang 28
Rome 27
Cambridge 24
Munich 20
Redwood City 20
Princeton 18
Bremen 16
Helsinki 16
Mountain View 15
Brussels 14
Izmir 12
Los Angeles 11
Lancaster 9
Norwalk 9
University Park 9
Boardman 8
Changsha 8
Hangzhou 8
Hebei 8
Jiaxing 8
Nürnberg 8
Shenyang 8
Tianjin 8
Bursa 7
Busto Arsizio 7
Pune 7
Fremont 6
Corbetta 5
Kunming 5
London 5
San Diego 5
Washington 5
Hefei 4
Leawood 4
Shanghai 4
Brno 3
Detroit 3
Dong Ket 3
Gent 3
Jinan 3
Kish 3
Millbury 3
Redmond 3
Simi Valley 3
Toronto 3
Zhengzhou 3
Acton 2
Albuquerque 2
Ankara 2
Augusta 2
Brisbane 2
Chicago 2
Chiswick 2
Fonte Nuova 2
Groningen 2
Guangzhou 2
Guatemala City 2
Iasi 2
Indiana 2
Madrid 2
Menlo Park 2
Napoli 2
Nuremberg 2
Phoenix 2
Sacramento 2
Southend 2
São Paulo 2
Tappahannock 2
Zurich 2
Abidjan 1
Agrate Brianza 1
Amman 1
Amsterdam 1
Andover 1
Ardabil 1
Totale 2.420
Nome #
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 319
Human obesity and endothelium-dependent responsiveness 271
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 143
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 134
Effects of GLP-1 on Forearm Vasodilator Function and Glucose Disposal During Hyperinsulinemia in the Metabolic Syndrome 121
Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review 100
Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy 99
Vascular Effects of Obestatin in Lean and Obese Subjects 94
Coexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans 93
Ghrelin Restores the Endothelin 1/Nitric Oxide Balance in Patients With Obesity-Related Metabolic Syndrome 83
Beneficial Effects of Apelin on Vascular Function in Patients with Central Obesity 83
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 80
Endothelial and perivascular adipose tissue abnormalities in obesity-related vascular dysfunction: novel targets for treatment 79
Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome. 75
Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome 75
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 75
Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity 75
Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome. 74
Obesity and kidney disease: Beyond the hyperfiltration 73
CD26: a multi-purpose pharmacological target 71
Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome 70
Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity 66
Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome 64
Rho Kinase Inhibition Improves Forearm Vasodilator Responsiveness During Hyperinsulinemia in the Metabolic Syndrome. 61
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease 61
PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia 60
Gut hormones and endothelial dysfunction in patients with obesity and diabetes 57
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome 55
Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease 52
Obesity, blood vessels and metabolic syndrome 51
Insulinemia and the risk of breast cancer and its relapse 50
Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease 50
Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue 50
Oxidative stress in diabetes: implications for vascular and other complications 49
Increased fractalkine and vascular dysfunction in obesity and in type 2 diabetes. Effects of oral antidiabetic treatment 49
Arterial ageing: from endothelial dysfunction to vascular calcification 46
Calcification biomarkers and vascular dysfunction in obesity and type 2 diabetes: influence of oral hypoglycemic agents. 46
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 45
Vasodilator Dysfunction in Human Obesity: Established and Emerging Mechanisms 45
Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque 44
Increased endothelin-1-mediated vasoconstrictor tone in human obesity: effects of gut hormones 43
Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy 42
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome 41
Drug treatments to restore vascular function and diabesity 41
Sex-specific effects of cardiovascular risk factors on endothelium-dependent dilation and endothelin activity in middle-aged women and men. 40
The vascular endothelin system in obesity and type 2 diabetes: Pathophysiology and therapeutic implications 38
Exercise is medicine: key to cardiovascular disease and diabetes prevention 38
Lp-PLA 2 , a new biomarker of vascular disorders in metabolic diseases 37
Intricacies of the endothelin system in human obesity: Role in the development of complications and potential as a therapeutic target 35
Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque 34
Variable changes of circulating angptl3 and angptl4 in different obese phenotypes: Relationship with vasodilator dysfunction 34
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 33
Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome. 33
Variable dysregulation of circulating lipocalin-2 in different obese phenotypes: Association with vasodilator dysfunction 32
Mirabegron relaxes arteries from human visceral adipose tissue through antagonism of α1-adrenergic receptors 19
Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity 14
Mirabegron relaxes arteries from human visceral adipose tissue through antagonism of α1-adrenergic receptors 11
Totale 3.853
Categoria #
all - tutte 17.234
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.234


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020387 0 0 0 0 27 41 74 26 26 34 111 48
2020/2021464 33 51 11 47 68 59 44 16 64 18 43 10
2021/2022388 33 32 8 17 32 13 5 69 20 29 63 67
2022/2023859 106 110 72 116 50 116 38 72 114 27 27 11
2023/2024485 21 133 14 17 23 82 40 30 7 19 31 68
2024/2025198 21 19 76 36 46 0 0 0 0 0 0 0
Totale 3.853